99% Savings - Buy Just @1 Rs X
Vicard T 2 Tablet is a commercial drug that is prescribed in the form of Tablet. It is typically used for the treatment of High BP. Vicard T 2 Tablet also has some secondary and off-label uses. These are listed below.
Medical history of the patient along with age and gender determines the dosage of Vicard T 2 Tablet. The condition it has been prescribed for, and the route of administration also determine the right dosage. Refer to the dosage section for a detailed discussion.
The most common side effects of Vicard T 2 Tablet are Nasal congestion, Sinus inflammation. Apart from the aforementioned side effects, Vicard T 2 Tablet can also lead to other problems, which have been listed below. Normally, these side effects of Vicard T 2 Tablet are not long lasting and go away when the treatment is finished. Consult your doctor if these side effects become worse or stay for a longer duration.
Furthermore, you should know that effect of Vicard T 2 Tablet is Severe for pregnant women and Severe for women who are breastfeeding. Further, the section on Vicard T 2 Tablet related warnings talks about Vicard T 2 Tablet's effects on the liver, heart and kidney.
Vicard T 2 Tablet is contraindicated in people with pre-existing medical conditions like Low Blood Pressure (Hypotension) as it can result in adverse effects. The section on Vicard T 2 Tablet contraindications lists all such conditions.
Additionally, Vicard T 2 Tablet may also adversely react with other medicines. See below for a complete list.
In addition to these precautions, you may also note that Vicard T 2 Tablet is not safe while driving, and is is not addictive in nature.
Vicard T 2 Tablet is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Vicard T 2 Tablet safe for pregnant women?
Vicard T can cause severe side effects if taken during pregnancy, so, pregnant women should talk to their doctor before taking it.
Is the use of Vicard T 2 Tablet safe during breastfeeding?
Taking Vicard T may lead to serious side effects if you are breastfeeding. Vicard T should not be taken by breastfeeding women unless prescribed by the doctor.
What is the effect of Vicard T 2 Tablet on the Kidneys?
There are no side effects of Vicard T on the kidneys.
What is the effect of Vicard T 2 Tablet on the Liver?
Vicard T has very mild side effects on the liver.
What is the effect of Vicard T 2 Tablet on the Heart?
Side effects of Vicard T rarely affect the heart.
If you are suffering from any of the following diseases, you should not take Vicard T 2 Tablet unless your doctor advises you to do so -
Is this Vicard T 2 Tablet habit forming or addictive?
Vicard T 2 Tablet does not cause addiction.
Is it safe to drive or operate heavy machinery when consuming?
You may feel sleepy or tired after taking Vicard T 2 Tablet. So it is best to avoid driving.
Is it safe?
Vicard T 2 Tablet is safe but it is important to consult a doctor before taking it.
Is it able to treat mental disorders?
No, the use of Vicard T 2 Tablet in mental disorders is not effective.
Interaction between Food and Vicard T 2 Tablet
Taking Vicard T 2 Tablet with food is safe.
Interaction between Alcohol and Vicard T 2 Tablet
Consuming Vicard T 2 Tablet with alcohol can have many serious effects on your body.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Hytrin (terazosin hydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 142
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1180-1182